About Sequence Bio
Sequence Bio is a company founded in 2013.. Sequence Bio has raised $5.47 million across 4 funding rounds from investors including Y Combinator, DCVC and Killick Capital. Sequence Bio offers products and services including Genetics Platform and Discovery Cohorts. Sequence Bio operates in a competitive market with competitors including Omniome, Novogene Corporation, HitGen, Singular Genomics and Slingshot Bioscience, among others.
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sequence Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.47 M (USD)
in 4 rounds
-
Latest Funding Round
$1.32 M (USD), Seed
Jul 30, 2019
-
Investors
Y Combinator
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sequence Bio
Sequence Bio offers a comprehensive portfolio of products and services, including Genetics Platform and Discovery Cohorts. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for systems biology to identify disease signals in genetics.
Service providing powered cohorts for disease research and drug development.
Unlock access to complete
Funding Insights of Sequence Bio
Sequence Bio has successfully raised a total of $5.47M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.32 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $1.3M
-
First Round
First Round
(19 Oct 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Seed - Sequence Bio | Valuation |
investors |
|
| Jun, 2019 | Amount | Seed - Sequence Bio | Valuation | Y Combinator |
|
| Jun, 2016 | Amount | Seed - Sequence Bio | Valuation | DCVC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sequence Bio
Sequence Bio has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Y Combinator, DCVC and Killick Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Killick Capital is engaged in private equity investments in Canada.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sequence Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sequence Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sequence Bio Comparisons
Competitors of Sequence Bio
Sequence Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, HitGen, Singular Genomics and Slingshot Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Next-generation gene sequencing and multi-omics technologies are provided.
|
|
| domain | founded_year | HQ Location |
Next-generation synthetic cells are developed for diagnostics and therapeutics.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sequence Bio
Frequently Asked Questions about Sequence Bio
When was Sequence Bio founded?
Sequence Bio was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Who is the current CEO of Sequence Bio?
Chris C Gardner is the current CEO of Sequence Bio.
Is Sequence Bio a funded company?
Sequence Bio is a funded company, having raised a total of $5.47M across 4 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Oct 19, 2015.
What does Sequence Bio do?
Sequence Bio was established in 2013 in Newfoundland and Labrador, Canada, as a data-driven biotechnology company. A 100,000-person genome sequencing project is led by the firm to analyze genetic data for medical applications. Operations center on genomic research and data processing to support advancements in disease treatment and pharmaceutical development within the biotechnology sector. The company is headquartered in the region with Chris C. Gardner serving as CEO and President.
Who are the top competitors of Sequence Bio?
Sequence Bio's top competitors include Novogene Corporation, BGI and Singular Genomics.
What products or services does Sequence Bio offer?
Sequence Bio offers Genetics Platform and Discovery Cohorts.
Who are Sequence Bio's investors?
Sequence Bio has 5 investors. Key investors include Y Combinator, DCVC, Killick Capital, Klister Credit, and Pelorus Venture Capital.